全文获取类型
收费全文 | 31171篇 |
免费 | 2899篇 |
国内免费 | 1467篇 |
专业分类
耳鼻咽喉 | 280篇 |
儿科学 | 386篇 |
妇产科学 | 545篇 |
基础医学 | 6571篇 |
口腔科学 | 563篇 |
临床医学 | 1656篇 |
内科学 | 3786篇 |
皮肤病学 | 669篇 |
神经病学 | 1596篇 |
特种医学 | 480篇 |
外国民族医学 | 15篇 |
外科学 | 2402篇 |
综合类 | 4242篇 |
现状与发展 | 6篇 |
预防医学 | 934篇 |
眼科学 | 296篇 |
药学 | 3275篇 |
2篇 | |
中国医学 | 714篇 |
肿瘤学 | 7119篇 |
出版年
2024年 | 82篇 |
2023年 | 485篇 |
2022年 | 924篇 |
2021年 | 1169篇 |
2020年 | 936篇 |
2019年 | 846篇 |
2018年 | 771篇 |
2017年 | 793篇 |
2016年 | 788篇 |
2015年 | 1093篇 |
2014年 | 1562篇 |
2013年 | 1602篇 |
2012年 | 1428篇 |
2011年 | 1804篇 |
2010年 | 1663篇 |
2009年 | 1688篇 |
2008年 | 1716篇 |
2007年 | 1764篇 |
2006年 | 1606篇 |
2005年 | 1527篇 |
2004年 | 1460篇 |
2003年 | 1388篇 |
2002年 | 1200篇 |
2001年 | 1088篇 |
2000年 | 979篇 |
1999年 | 803篇 |
1998年 | 709篇 |
1997年 | 615篇 |
1996年 | 510篇 |
1995年 | 404篇 |
1994年 | 271篇 |
1993年 | 203篇 |
1992年 | 152篇 |
1991年 | 123篇 |
1990年 | 81篇 |
1989年 | 86篇 |
1988年 | 103篇 |
1987年 | 75篇 |
1986年 | 91篇 |
1985年 | 143篇 |
1984年 | 145篇 |
1983年 | 81篇 |
1982年 | 106篇 |
1981年 | 82篇 |
1980年 | 76篇 |
1979年 | 57篇 |
1978年 | 51篇 |
1977年 | 51篇 |
1976年 | 40篇 |
1975年 | 32篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
61.
三氧化二砷对人脐静脉内皮细胞中蛋白激酶C活性和白细胞介素-15分泌、表达的影响及其临床意义 总被引:2,自引:2,他引:0
目的 通过研究三氧化二砷(As2O3)对人脐静脉内皮细胞(HUVEC)中蛋白激酶C(PKC)活性和白细胞介素(IL)-15表达和分泌的影响,探讨内皮细胞在As2O3抑制白血病或肿瘤中的作用。方法用不同浓度的As2O3作用于培养的HUVEC细胞,测定其生长情况、胞膜和胞浆PKC活性以及对IL-15基因表达和分泌的影响。结果0.25 μmol/L~50 μmol/L的.As2O3均抑制HUVEC细胞的增殖(P<0.01),随着药物浓度或作用时间的增加,细胞逐渐死亡。在As2O3作用细胞4 h测定胞浆和胞膜的PKC活性,两者在不同浓度作用下活性水平均得到提升(P<0.01),但胞膜的活性上升幅度更大。在As2O3的测定浓度范围内,PKC的活性水平与As2O3的浓度呈正相关。1、5、16 μmol/L的As2O3导致IL-15基因表达和分泌水平的增加(P<0.01),并呈浓度依赖性关系。结论As2O3可能是通过激活内皮细胞的PKC活性,促进IL-15或其他细胞因子的分泌,来抑制白血病或肿瘤发展的。 相似文献
62.
Anders Persson Stefan Pauli Christer Halldin Sharon Stone-Elander Lars Farde Irene Sjgren Gran Sedvall 《Human psychopharmacology》1989,4(1):21-31
The 11C-labelled benzodiazepine antagonist Ro 15–1788 (flumazenil) and positron emission tomography (PET) were used to determine quantitative characteristics of benzodiazepine receptor binding in the neocortex of healthy young men. Saturating doses of unlabelled flumazenil administered i.v., before or together with the ligand-reduced 11C-flumazenil accumulation in the neocortex by about 90 per cent. Saturating doses of unlabelled flumazenil had little effect on the accumulation of radioactivity in the benzodiazepine receptor-poor regions such as pons or white matter. By giving graded doses of unlabelled flumazenil together with the tracer, saturation isotherms were obtained allowing the calculation of receptor density (Bmax) and equilibrium dissociation constant (Kd) values on the basis of certain assumptions Bmax values were in the order of 90 pmol/g and Kd values in the order of 10 nM in the neocortex. Scatchard and Hill plots of the radioactivity data indicated that 11C-flumazenil binds to saturable sites of a homogeneous population. The data indicate that intravenous doses of 1 or 2 mg flumazenil result in a benzodiazepine receptor occupancy of about 50 per cent. The method described should be useful for studying regional differences in benzodiazepine receptor characteristics in the living human brain in healthy subjects and neuropsychiatric disorders, and also in relation to treatment with drugs interacting with benzodiazepine receptors. 相似文献
63.
64.
65.
66.
聚合酶链反应单链构象多态性检测乳腺癌中P53基因突变 总被引:4,自引:0,他引:4
应用聚合酶链反应单链构象多态性方法,对24例原发性乳腺癌肿瘤组织基因组DNA进行了分析,结果表明:其中7例存在P53基因的突变,突变频率约为30%。同时对其中10例进行Souternblot分析,有2例在chr17P上存在等位基因的缺失,而其另一等位基因上均存在基因突变。 相似文献
67.
Identification of genes associated with ovarian cancer metastasis using microarray expression analysis 总被引:1,自引:0,他引:1
J.M. LANCASTER H.K. DRESSMAN†‡ J.P. CLARKE§ R.A. SAYER M.A. MARTINO J.M. CRAGUN A.H. HENRIOTT J. GRAY¶ R. SUTPHEN A. ELAHI R.S. WHITAKER M. WEST# J.R. MARKS J.R. NEVINS†‡ & A. BERCHUCK 《International journal of gynecological cancer》2006,16(5):1733-1745
Although the transition from early- to advanced-stage ovarian cancer is a critical determinant of survival, little is known about the molecular underpinnings of ovarian metastasis. We hypothesize that microarray analysis of global gene expression patterns in primary ovarian cancer and metastatic omental implants can identify genes that underlie the metastatic process in epithelial ovarian cancer. We utilized Affymetrix U95Av2 microarrays to characterize the molecular alterations that underlie omental metastasis from 47 epithelial ovarian cancer samples collected from multiple sites in 20 patients undergoing primary surgical cytoreduction for advanced-stage (IIIC/IV) serous ovarian cancer. Fifty-six genes demonstrated differential expression between ovarian and omental samples (P < 0.01), and twenty of these 56 differentially expressed genes have previously been implicated in metastasis, cell motility, or cytoskeletal function. Ten of the 56 genes are involved in p53 gene pathways. A Bayesian statistical tree analysis was used to identify a 27-gene expression pattern that could accurately predict the site of tumor (ovary versus omentum). This predictive model was evaluated using an external data set. Nine of the 27 predictive genes have previously been shown to be involved in oncogenesis and/or metastasis, and 10/27 genes have been implicated in p53 pathways. Microarray findings were validated by real-time quantitative PCR. We conclude that gene expression patterns that distinguish omental metastasis from primary epithelial ovarian cancer can be identified and that many of the genes have functions that are biologically consistent with a role in oncogenesis, metastasis, and p53 gene networks. 相似文献
68.
L.E. Oostenbrug I.M. Nolte E. Oosterom G. van der Steege G.J. te Meerman H.M. van Dullemen J.P.H. Drenth D.J. de Jong K. van der Linde P.L.M. Jansen J.H. Kleibeuker 《Digestive and liver disease》2006,38(11):834-845
BACKGROUND: Three major polymorphisms of the Caspase-Activation Recruitment Domain containing protein 15 gene have been described to be associated with Crohn's disease. Genotype-phenotype studies reported in literature provide conflicting data on disease localisation and behaviour. We investigated the relation of Caspase-Activation Recruitment Domain containing protein 15 with inflammatory bowel disease and Crohn's disease phenotypic characteristics in a large Dutch cohort and performed a pooled analysis on inflammatory bowel disease patients and Crohn's disease phenotypic characteristics reported in association studies. METHODS: We genotyped 781 cases and 315 controls for the R702W, G908R and 1007fsinsC variants and for six microsatellite markers in and close to Caspase-Activation Recruitment Domain containing protein 15. In the pooled analysis data of 7201 inflammatory bowel disease patients and 3720 controls from 20 studies were included. RESULTS: Association was found for Crohn's disease with R702W and 1007fsinsC, including several disease characteristics, and not for ulcerative colitis. In the pooled analysis all three common Caspase-Activation Recruitment Domain containing protein 15 variants showed strong association with Crohn's disease (p<0.00001; odds ratio varying from 3.0 for single heterozygotes to 14.7 for compound heterozygotes) and not with ulcerative colitis. Phenotype analysis showed association with small bowel involvement, stricturing and penetrating disease. CONCLUSION: Caspase-Activation Recruitment Domain containing protein 15 is associated with Crohn's disease and not with ulcerative colitis. All three common Crohn's disease-associated variants are associated with small bowel involvement, the G908R and 1007fsinsC alleles also being associated with a complicated disease course. 相似文献
69.
70.
B. B. Y. Ma A. Oza E. Eisenhauer† G. Stanimir‡ M. Carey§ W. Chapman¶ E. Latta¶ K. Sidhu J. Powers† W. Walsh† A. Fyles 《International journal of gynecological cancer》2004,14(4):650-658
A multicenter phase II trial was conducted to define the activity of letrozole in postmenopausal women with recurrent or advanced endometrial carcinoma, who had no more than one prior line of progestins and never had chemotherapy (except adjuvant). Archival paraffin-embedded tumor samples were retrieved to determine the expression level of estrogen (ER) and progesterone receptor (PgR), p53, HER-2, bcl-2 and PTEN protein, and phosphorylation status of protein kinase B (PKB/Akt). Thirty-two eligible patients were treated with letrozole at 2.5 mg daily continuously, of whom 10 (31%) had prior progestins. Of the 28 patients evaluated for response, one complete and two partial responses were noted; overall response was 9.4% (95% confidence interval 2-25%). Eleven patients had stable disease for a median duration of 6.7 months (range 3.7-19.3 months). Amongst 22 patients who had tumor blocks available, the proportion showing positive expression of the following markers includes: PgR (86%), ER (86%), PTEN (82%), phosphorylated PKB/Akt (59%), bcl-2 (45%), p53 (32%), and HER-2 (0%). None of these markers correlated with response to letrozole or disease progression. In conclusion, letrozole is well tolerated but has little overall activity in this cohort of women with endometrial cancer. 相似文献